{"meshTagsMajor":["Kidney Transplantation","Practice Guidelines as Topic"],"meshTags":["Canada","Comorbidity","Creatinine","Epstein-Barr Virus Infections","Fertility","Glomerular Filtration Rate","Graft Rejection","Humans","Immunocompromised Host","Immunosuppression","Immunosuppressive Agents","Kidney Diseases","Kidney Transplantation","Monitoring, Physiologic","Papillomavirus Vaccines","Postoperative Care","Postoperative Complications","Practice Guidelines as Topic","Societies, Medical","Vaccination"],"meshMinor":["Canada","Comorbidity","Creatinine","Epstein-Barr Virus Infections","Fertility","Glomerular Filtration Rate","Graft Rejection","Humans","Immunocompromised Host","Immunosuppression","Immunosuppressive Agents","Kidney Diseases","Monitoring, Physiologic","Papillomavirus Vaccines","Postoperative Care","Postoperative Complications","Societies, Medical","Vaccination"],"publicationTypes":["Journal Article","Research Support, Non-U.S. Gov\u0027t"],"title":"Canadian Society of Transplantation and Canadian Society of Nephrology commentary on the 2009 KDIGO clinical practice guideline for the care of kidney transplant recipients.","pubmedId":"20659623"}